Pacira Pharm Inc (PCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 585,578 | 134,036 | 105,774 | 66,699 | 99,957 |
| Marketable Securities | 70,831 | 559,822 | 540,821 | 523,364 | 421,705 |
| Receivables | 96,318 | 49,975 | 68,357 | 52,583 | 53,046 |
| Inventories | 98,550 | 67,209 | 65,264 | 64,606 | 64,650 |
| TOTAL | $866,048 | $822,352 | $792,579 | $720,247 | $651,623 |
| Non-Current Assets | |||||
| PPE Net | 188,401 | 159,235 | 153,302 | 144,822 | 136,688 |
| Investments And Advances | 0 | 21,192 | 17,966 | 51,024 | 95,459 |
| Intangibles | 769,143 | 190,168 | 192,135 | 194,101 | 196,068 |
| Other Non-Current Assets | 251,761 | 163,055 | 169,851 | 177,355 | 194,675 |
| TOTAL | $1,209,305 | $533,650 | $533,254 | $567,302 | $622,890 |
| Total Assets | $2,075,353 | $1,356,002 | $1,325,833 | $1,287,549 | $1,274,513 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 24,234 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 10,543 | 7,895 | 12,179 | 9,110 | 10,431 |
| Accrued Expenses | 127,555 | 50,798 | 52,163 | 50,239 | 70,974 |
| Other current liabilities | N/A | 5,070 | 5,026 | 14,864 | 14,736 |
| TOTAL | $521,118 | $225,788 | $228,693 | $232,084 | $253,328 |
| Non-Current Liabilities | |||||
| Long Term Debt | 335,263 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 488,564 | 411,612 | 409,972 | 404,647 | 401,497 |
| TOTAL | $823,827 | $411,612 | $409,972 | $404,647 | $401,497 |
| Total Liabilities | $1,344,945 | $637,400 | $638,665 | $636,731 | $654,825 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 44,848 | 44,544 | 44,455 | 44,025 | 43,863 |
| Common Shares | 45 | 45 | 44 | 44 | 44 |
| Retained earnings | -211,895 | -206,765 | -224,425 | -243,506 | -253,875 |
| Other shareholders' equity | 167 | 153 | 181 | 172 | 318 |
| TOTAL | $730,408 | $718,602 | $687,168 | $650,818 | $619,688 |
| Total Liabilities And Equity | $2,075,353 | $1,356,002 | $1,325,833 | $1,287,549 | $1,274,513 |